Real-World 2-Year Outcomes of the Inspiron™ Biodegradable Polymer Sirolimus-Eluting Stent
Arquivos Brasileiros de Cardiologia · 2026 · 123 (9)
DOI: 10.36660/abc.20260244i ↗Kurz gefasst
Fachartikel in der Zeitschrift Arquivos Brasileiros de Cardiologia, 2026. Verfasst von Ricardo Czarnobai Soccol und 28 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scitech Medical TM.
Abstract (Originalsprache)
Background
The Inspiron™ sirolimus-eluting stent (SES) is a third-generation coronary stent featuring thin struts and an abluminal biodegradable polymer coating. Although it is widely used in Brazil, long-term real-world evidence remains limited.
Objectives
To evaluate the safety and effectiveness of the Inspiron™ SES over 24 months in an unselected population undergoing percutaneous coronary intervention (PCI).
Methods
This pooled analysis included 2,803 consecutive patients who underwent Inspiron™ SES implantation between June 2017 and January 2022 at 25 Brazilian centers. The primary endpoint was major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, MI, and target lesion revascularization (TLR) at 24 months. Kaplan-Meier survival analysis, Cox proportional hazards regression, and restricted cubic spline models were used. A two-sided p-value < 0.05 was considered statistically significant.
Results
At 24 months, the cumulative incidence of MACE was 6.7%, with rates of 5.4% for all-cause mortality, 2.3% for cardiovascular mortality, 1.2% for MI, 0.9% for TLR, and 0.6% for definite or probable stent thrombosis (ST). Patients with a vessel diameter < 2.5 mm had significantly higher rates of MACE, cardiovascular death, repeat revascularization, and ST (p = 0.022). Independent predictors of MACE included older age (p = 0.034), left main or three-vessel coronary artery disease (p = 0.024), and acute coronary syndrome as the indication for PCI (p < 0.001).
Conclusions
In this large real-world registry, the Inspiron™ SES demonstrated favorable safety and effectiveness through 24 months, with low rates of ST and repeat revascularization despite the inclusion of complex coronary lesions.
Förderung
- Scitech Medical TM
Zitieren
APA
Soccol, R. C., Ribeiro, H. B., Lasevitch, R., Pellegrini, D., Silva, E. E. R. D., Mattos, C. A. S. D., Filho, A. L., Takeshita, N., Câmara, S. S. P., Junior, J. D. R. C., Freitas, L. Z. F. D., Sabedotti, M., Teixeirense, P. T., Truffa, M. A. M., Gasperi, R. D., Abreu, E. D. S., Bassani, I. A., Mangione, J. A., Cavalieri, M., …, & Caramori, P. R. A. (2026). Real-World 2-Year Outcomes of the Inspiron™ Biodegradable Polymer Sirolimus-Eluting Stent. Arquivos Brasileiros de Cardiologia, 123(9). https://doi.org/10.36660/abc.20260244i
Vancouver
Soccol RC, Ribeiro HB, Lasevitch R, Pellegrini D, Silva EERD, Mattos CASD, et al. Real-World 2-Year Outcomes of the Inspiron™ Biodegradable Polymer Sirolimus-Eluting Stent. Arquivos Brasileiros de Cardiologia. 2026;123(9). doi:10.36660/abc.20260244i
BibTeX
@article{Soccol2026,
author = {Soccol, Ricardo Czarnobai and Ribeiro, Henrique Barbosa and Lasevitch, Ricardo and Pellegrini, Denise and Silva, Expedito Eustáquio Ribeiro da and Mattos, Carlos Alberto Santos de and Filho, Augusto Lima and Takeshita, Noriaki and Câmara, Sílvio Sérgio Pontes and Junior, José de Ribamar Costa and Freitas, Leandro Zacarias Figueiredo de and Sabedotti, Marcelo and Teixeirense, Pablo Tomé and Truffa, Márcio Augusto Meirelles and Gasperi, Ricardo de and Abreu, Ewerton de Souza and Bassani, Ismael Arcari and Mangione, José Armando and Cavalieri, Maurício and Alves, Gustavo Martins Pereira and Andrade, Pedro Beraldo de and Maestri, Rafael and Cavalcanti, Rafael Rebêlo César and Paiva, Maria Sanali and Hirga, Marcelo de Oliveira and Arruda, José Airton de and Pivatelli, Flávio Correa and Zandomenico, Julia Gonçalves and Caramori, Paulo R. A.},
title = {Real-World 2-Year Outcomes of the Inspiron™ Biodegradable Polymer Sirolimus-Eluting Stent},
journal = {Arquivos Brasileiros de Cardiologia},
year = {2026},
volume = {123},
number = {9},
doi = {10.36660/abc.20260244i}
}
EUVIMED